Australia Dialysis Market is expected to reach USD 0.84 billion by 2030

The increasing aging population will propel the dialysis market during the forecast period.

Australia Dialysis Market is valued at USD 0.60 billion in 2023, and is expected to reach USD 0.84 billion by 2030, with a CAGR of 4.9% from 2024 to 2030, according to new research by Next Move Strategy Consulting.

The growth of the Australian dialysis market is significantly propelled by the aging demographic, manifesting a multifaceted impact on the prevalence and management of kidney-related disorders.

This demographic shift accentuates an increasing need for dialysis services, as the aging population becomes more susceptible to conditions affecting the kidneys. Consequently, the expansion of the dialysis market is intricately tied to the rising demand for comprehensive renal care driven by the challenges posed by kidney-related ailments within an aging population.

Moreover, the advancements in healthcare technology are driving significant growth in the dialysis market. These innovations, such as user-friendly home haemodialysis machines with remote monitoring capabilities, are extending life expectancy for a broader demographic living with chronic conditions. Companies such as Signify Health, a CVS Health subsidiary, are introducing comprehensive in-home assessments for kidney health.

These screenings, provided as part of their In-home Health Evaluation, aim to identify and diagnose kidney issues early, offering convenience and cost savings for individuals under Medicare Advantage coverage. This reflects a positive shift towards more accessible and proactive patient care.

However, a significant challenge in the Australian dialysis market is the inherent risk of infections and complications associated with these procedures. Poor adherence to stringent hygiene practices and inadequate sterilization measures can elevate infections, posing a threat to patient health.

Additionally, complications arising from the dialysis process itself can contribute to treatment challenges. Addressing these risks through rigorous quality control measures, training healthcare professionals, and promoting adherence to established protocols is essential to enhance the safety profile of dialysis treatments, fostering better patient outcomes and confidence in the market.

On the contrary, the introduction of at-home dialysis solutions is creating growth opportunity for the Australia dialysis market, where patients can use dialysis solutions at home. This approach enhances patient comfort, reduces the need for frequent hospital visits, and provides a flexible kidney care option.

As more individuals prefer the convenience of managing their dialysis in the comfort of their homes, companies that provide user-friendly and portable dialysis equipment stand to capture a significant market share. By addressing the growing demand for home-based healthcare solutions, the dialysis market can attract a broader customer base and foster long-term patient satisfaction, contributing to overall market growth.

Request a sample here:

According to the report, leading players in the Australia dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Key Insights from the Australia Dialysis Market Report:

  • The information related to key drivers, restraints, and opportunities and their impact on the Australia dialysis market is provided in the report.

  • The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.

  • The market share of the Australia dialysis market and their competitive analysis are provided in the report. 

Share this post?


No comment available , be the first one!

Leave a Reply